Opiant Pharmaceuticals, Inc.

Opiant Pharmaceuticals, Inc.

OPNT
Opiant Pharmaceuticals, Inc.US flagNASDAQ Capital Market
20.65
USD
- -
- -
108.80MMarket Cap

Opiant Pharmaceuticals, Inc. (OPNT) Stock Split History

Learn about Opiant Pharmaceuticals, Inc.'s most recent 1-for-100 basis stock split on December 31, 2014. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Opiant Pharmaceuticals, Inc.'s most recent stock split

Split Date: 2014-12-31
Split Ratio: 1:100
Price Before Split: $0.42
Price After Split: $0.00

Developer API

Get OPNT split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/OPNT

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 100.00 times fewer shares (a 1:100 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Opiant Pharmaceuticals, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2014-12-311:100Yes$0.42$0.00

About Opiant Pharmaceuticals, Inc.

Company overview and industry information

Opiant Pharmaceuticals, Inc. (OPNT) operates in the Biotechnology industry. The recent 1-for-100 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Opiant Pharmaceuticals, Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.